Literature DB >> 12842621

Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1.

Masakazu Tanaka1, Takaharu Ueno, Tomomi Nakahara, Kenta Sasaki, Akinori Ishimoto, Hiroyuki Sakai.   

Abstract

Downregulation of virus receptors on the cell surface is considered to be important in preventing superinfection. HIV-1 encodes multiple gene products, Env, Vpu, and Nef, involved in downregulation of CD4, a major HIV-1 receptor. We found that simultaneous mutations in both vpu and nef severely impaired virus replication. We examined the involvement of CD4 downregulation mediated by Vpu and Nef in the modification of virus infectivity. The mutation in vpu increased CD4 incorporation into virions without affecting the Env content in it, inhibiting the attachment step of virions to the CD4-positive cell surface. Although a single mutation in nef suppresses virus infectivity via a CD4-independent mechanism, it could augment CD4 incorporation in virions in combination with a vpu mutation. These results indicated that CD4 downregulation was necessary for maintenance of Env function in the virion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842621     DOI: 10.1016/s0042-6822(03)00126-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  A post-entry role for CD63 in early HIV-1 replication.

Authors:  Guangyu Li; Natallia Dziuba; Brian Friedrich; James L Murray; Monique R Ferguson
Journal:  Virology       Date:  2011-02-26       Impact factor: 3.616

2.  Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.

Authors:  Raul Perez; Sonia Gibson; Pablo Lopez; Ellen Koenig; Marisol De Castro; Yasuhiro Yamamura
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-07       Impact factor: 2.205

3.  CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies.

Authors:  Shilei Ding; Romain Gasser; Gabrielle Gendron-Lepage; Halima Medjahed; William D Tolbert; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.

Authors:  Woan-Eng Chan; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu.

Authors:  Sanath Kumar Janaka; Tiffany M Lucas; Marc C Johnson
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

6.  Evidences for viral strain selection in late stages of HIV infection: an analysis of Vpu alleles.

Authors:  Marcos Vinícius Pereira Gondim; Joaquim Xavier da Silva; Francisco Prosdocimi; Eduardo Leonardecz-Neto; Octávio Luiz Franco; Enrique Roberto Argañaraz
Journal:  Protein J       Date:  2012-02       Impact factor: 2.371

7.  Supervised learning and prediction of physical interactions between human and HIV proteins.

Authors:  Matthew D Dyer; T M Murali; Bruno W Sobral
Journal:  Infect Genet Evol       Date:  2011-03-05       Impact factor: 3.342

8.  Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.

Authors:  Kei Sato; Jun Aoki; Naoko Misawa; Eriko Daikoku; Kouichi Sano; Yuetsu Tanaka; Yoshio Koyanagi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Authors:  Maria Iglesias-Ussel; Claire Vandergeeten; Luigi Marchionni; Nicolas Chomont; Fabio Romerio
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

Review 10.  Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Authors:  Philip Mwimanzi; Tristan J Markle; Takamasa Ueno; Mark A Brockman
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.